Rabies Immunoglobulin Market

1. Rabies Immunoglobulin Market Analysis By Industry Size, Share, Revenue Growth Demand and Forecast – 2028 The global rabies immunoglobulin market is anticipated to grow at a CAGR of 6.1% during the forecast period. As a zoonotic disease, it requires close cross-sectoral coordination at the national, regional, and global levels. The rising government initiatives in the market are expected to surge the market growth during the forecast period. Rabies is included in WHO’s new 2021-2030 road map. The 2030 NTD Roadmap is a guiding document for the global response to NTDs and includes regional, progressive targets for rabies elimination. For instance, in 2021, WHO, Food and Agriculture Organization, and World Organization for Animal Health, have prioritized rabies under a one-health approach and launched the ‘United Against Rabies Forum’ (UAR), a multi-stakeholder platform. Moreover, UAR initiates investments in rabies control and coordinates the global rabies elimination efforts to achieve zero human deaths from dog-mediated rabies by 2030. Thus, progress in rabies elimination indicates one-health operationalization and strengthened human and animal health systems. To Request a Sample of our Report on Rabies Immunoglobulin Market https://www.omrglobal.com/request-sample/rabies-immunoglobulin-market Furthermore, in 2019, Gavi included human rabies vaccines in its vaccine investment strategy 2021-2025 which will support scaling up rabies PEP in Gavi-eligible countries. Its rollout has been disrupted due to the COVID-19 pandemic, the WHO will continue to advise on best strategies and practices for its rollout to countries requesting rabies vaccine. On the path towards rabies elimination, countries can request WHO validation of achieving zero human deaths from dog- mediated rabies; seek OIE endorsement of their dog rabies control programs and self-declared freedom from dog rabies. Additionally, Mexico was the first country to have been validated by WHO in 2019 for eliminating human deaths from dog-mediated rabies. A full Report of Rabies Immunoglobulin Market is available @ https://www.omrglobal.com/industry- reports/rabies-immunoglobulin-market Market Coverage The market number available for – 2021-2028 Base year- 2021 Forecast period- 2022-2028 Segment Covered By Type Regions Covered North America Europe Asia-Pacific Rest of the World Competitive Landscape- including Bharat Serums and Vaccines Ltd. (BSV), CSL Behring, Grifols SA, Guangdong Shuanglin Bio-Pharmacy Co, Ltd., and others. Key questions addressed by the report What is the market growth rate? Which segment and region dominate the market in the base year?

2. Which segment and region will project the fastest growth in the market? Who is the leader in the market? How players are addressing challenges to sustain growth? Where is the investment opportunity? Global Rabies Immunoglobulin Market Report Segment By Type Human Rabies Immune Globulin (HRIG) Equine Rabies Immunoglobulin (ERIG) For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/rabies-immunoglobulin-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404